Show simple item record

dc.creatorMraović, Mirjana
dc.creatorČanić-Radojlović, M.
dc.date.accessioned2021-02-18T10:16:43Z
dc.date.available2021-02-18T10:16:43Z
dc.date.issued1986
dc.identifier.issn0300-8126
dc.identifier.urihttp://intor.torlakinstitut.com/handle/123456789/30
dc.description.abstractThe return of multiresistant Staphylococcus aureus strains and the appearance of methicillin-resistant strains resistant as well to rifampin and fusidic acid increase the need for new agents to treat infections caused by such strains. Ofloxacin susceptibility of 109 selected methicillin-resistant staphylococci (with MIC90 of 1,000 mg/l for methicillin, 1.3% being resistant to gentamicin with MICs ranging from 25 to 100 mg/l, chloramphenicol MICs ranging from 25 to 100 mg/l and resistant to β-lactam-antibiotics and clindamycin), was determined by an agar dilution method. MICs of ofloxacin for methicillin-resistant staphylococci ranged from 0.09 to 0.78 mg/l, with an MIC90 of 0.39 mg/l. The in vitro results suggest a possible clinical role for ofloxacin in infections caused by methicillin-resistant staphylococci. However, further investigations are needed.en
dc.publisherSpringer-Verlag
dc.rightsrestrictedAccess
dc.sourceInfection
dc.titleThe activity of ofloxacin against methicillin-resistant staphylococcus aureusen
dc.typearticle
dc.rights.licenseARR
dc.citation.epageS232
dc.citation.issue4 Supplement
dc.citation.other14(4 Supplement): S231-S232
dc.citation.rankM22
dc.citation.spageS231
dc.citation.volume14
dc.identifier.doi10.1007/BF01661278
dc.identifier.pmid3469151
dc.identifier.rcubconv_559
dc.identifier.scopus2-s2.0-0022845799
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record